Table 1.

PDC numbers and MxA expression in WAS spleen

Case MxA score MxA pDCs Clinical score/autoimmunity 
  %   
WAS#1 18.52 6.21 5/+ 
WAS#2 13.23 203.92 5/− 
WAS#3 7.99 154.98 5/− 
WAS#4 2.89 228.76 5/+ 
WAS#5 19.02 50.40 3/− 
WAS#6 1.03 93.71 3/− 
WAS#7 13.95 323.48 5/+ 
WAS#8 13.61 8.68 5/+ 
Mean (±SD) 3 11.28 (±6.7) 133.8 (±113.9)  
CTR#1 14.44 131.15  
CTR#2 0.47 578.25  
CTR#3 1.6 202.63  
CTR#4 0.15 223.00  
CTR#5 4.21 NV  
CTR#6 25.29 202.63  
CTR#7 10.24 156.26  
CTR#8 0.61 62.95  
CTR#9 ne ne 83.21  
CTR#10 20.48 43.80  
Mean (±SD) 2.3 7.12 (±9.5) 187.10 (±160.30)  
Case MxA score MxA pDCs Clinical score/autoimmunity 
  %   
WAS#1 18.52 6.21 5/+ 
WAS#2 13.23 203.92 5/− 
WAS#3 7.99 154.98 5/− 
WAS#4 2.89 228.76 5/+ 
WAS#5 19.02 50.40 3/− 
WAS#6 1.03 93.71 3/− 
WAS#7 13.95 323.48 5/+ 
WAS#8 13.61 8.68 5/+ 
Mean (±SD) 3 11.28 (±6.7) 133.8 (±113.9)  
CTR#1 14.44 131.15  
CTR#2 0.47 578.25  
CTR#3 1.6 202.63  
CTR#4 0.15 223.00  
CTR#5 4.21 NV  
CTR#6 25.29 202.63  
CTR#7 10.24 156.26  
CTR#8 0.61 62.95  
CTR#9 ne ne 83.21  
CTR#10 20.48 43.80  
Mean (±SD) 2.3 7.12 (±9.5) 187.10 (±160.30)  

ne = not evaluable. MxA is expressed as the percentage of reactivity of the spleen area. pDCs are expressed as BDCA-2+ cells/mm2spleen area. Absolute pDC count and MxA expression were quantified on spleen sections of WAS patients. The MxA score was evaluated by counting the percentage of MxA+ cells and expressed as a four-tier scale. MxA percentage of reactivity of the spleen area and BDCA-2+ cells/mm2 spleen area were evaluated automatically on digital slides as described in Materials and methods. Disease score is given according to the classification reported previously (Imai et al., 2004)

or Create an Account

Close Modal
Close Modal